EPM2A Protein (AA 1-331) (His tag)
-
- Target Alle EPM2A Proteine anzeigen
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 1-331
-
Spezies
- Hund
-
Quelle
- Hefe
- Aufreinigungstag / Konjugat
- Dieses EPM2A Protein ist gelabelt mit His tag.
- Applikation
- ELISA
- Sequenz
- MRFRFGVVVP PAGAGAAPEL LVVGSRPELG RWEPRGAVRL RPAGSAAGGG ARALQEPGLW LGEVELAPGE AARDGAEPAR VDTFWYKFLK REPGGALSWE GNGPHHDRCC TYNENNLVDG VYCLPIGHWI EATGHTNEMK HTTDFYFNIA GHQAMHYSRI LPNIWLGSCP RQVEHITIKL KHELGITAVM NFQTEWDIVQ NSSGCNRYPE PMTPDTMIKL YKEEGLVYIW MPTPDMSTEG RVQMLPQAVC LLHALLENGH TVYVHCNAGV GRSTAAVCGW LQYVMGWNLR KVQYFLMAKR PAVYIDEDAL ARAEEDFFQK FGKVRSSVCS V
- Spezifität
- Canis familiaris (Dog) (Canis lupus familiaris)
- Produktmerkmale
- Please inquire if you are interested in this recombinant protein expressed in E. coli, mammalien cells or by baculovirus infection. Be aware about differences in price and lead time.
- Reinheit
- > 90 %
- Top Product
- Discover our top product EPM2A Protein
-
-
- Kommentare
-
The yeast protein expression system is the most economical and efficient eukaryotic system for secretion and intracellular expression. A protein expressed by the mammalian cell system is of very high-quality and close to the natural protein. But the low expression level, the high cost of medium and the culture conditions restrict the promotion of mammalian cell expression systems. The yeast protein expression system serve as a eukaryotic system integrate the advantages of the mammalian cell expression system. A protein expressed by yeast system could be modificated such as glycosylation, acylation, phosphorylation and so on to ensure the native protein conformation. It can be used to produce protein material with high added value that is very close to the natural protein. Our proteins produced by yeast expression system has been used as raw materials for downstream preparation of monoclonal antibodies.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 0.2-2 mg/mL
- Buffer
- Tris-based buffer, 50 % glycerol
- Handhabung
- Repeated freezing and thawing is not recommended. Store working aliquots at 4 °C for up to one week
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C, for extended storage, conserve at -20 °C or -80 °C.
-
- Target
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
- Andere Bezeichnung
- Laforin (EPM2A) (EPM2A Produkte)
- Synonyme
- TG-B Protein, Tg(TcraK,TcrbK)TG-BFlv Protein, EPM2 Protein, MELF Protein, laforin Protein, EPM2A, laforin glucan phosphatase Protein, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha Protein, EPM2A Protein, Epm2a Protein
- Hintergrund
-
Recommended name: Laforin.
EC= 3.1.3.16.
EC= 3.1.3.48.
Alternative name(s): Lafora PTPase.
Short name= LAFPTPase - UniProt
- Q1M199
- Pathways
- Cellular Glucan Metabolic Process
-